Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H I - J - K - L - M N - O - P - Q - R - S T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter C

GENERIC NAME

TRADE NAME

CONDITION

STUDY CODE

STUDY NAME

ACCESS TO STUDY / PROTOCOL

ACCESS TO RESULTS

CABAZITAXEL

Jevtana

Prostate Cancer

LPS14201

CARD

NCT02485691

CABAZITAXEL

Jevtana

Prostatic Neoplasms

EFC6193

TROPIC

NCT00417079

CABAZITAXEL

Jevtana

Prostatic Neoplasms

EFC11784

FIRSTANA

NCT01308567

CABAZITAXEL

Jevtana

Neoplasms, Malignant

TCD11068

NA

NCT01001221

CABAZITAXEL

Jevtana

Cancer, Gastric

ARD12417

GASTANA

NCT01497964

CABAZITAXEL

Jevtana

Small Cell Lung Cancer

ARD12166

NA

NCT01500720

CABAZITAXEL

Jevtana

Prostatic Neoplasms

CABAZ_L_05933

SWITCH

NCT01576029

CABAZITAXEL

Jevtana

Prostatic Neoplasms

CABAZ_L_06003

PROSPECTA

NCT01649635

CABAZITAXEL

Jevtana

Neoplasms, malignant

POP12251

NA

NCT01527929

CABAZITAXEL

Jevtana

Neoplasms, malignant

POP6792

NA

NCT01140607

CABAZITAXEL

Jevtana

Prostate Cancer, Hormone Refractory

TED11576

NA

NCT01324583

CABAZITAXEL

Jevtana

Prostate Cancer

TCD12128

NA

NCT01511536

CABAZITAXEL

Jevtana

Prostatic Neoplasms

CABAZ_C_05331

NA

EudraCT:2010-021128-92

CABAZITAXEL

Jevtana

Prostate Cancer

CABAZL06499

NA

NCT02074137

CABAZITAXEL

Jevtana

Solid Tumors

TED12689

NA

NCT01751308

CABAZITAXEL

Jevtana

Prostate Cancer

EFC11785

PROSELICA

EudraCT: 2010-022163-35

CABAZITAXEL

Jevtana

Prostate Cancer

CABAZL06056

TAXYNERGY

NCT01718353

CABAZITAXEL

Jevtana

Prostate Cancer

CABAZL07239

PEGAZUS

NCT02441894

CABAZITAXEL

Jevtana

Prostate Cancer

LPS14022

PRIMCAB

NCT02379390

CAPECITABINE/CYCLOPHOSPHAMIDE

Not marketed

Breast Cancer Metastatic

CAPCYR07568

METRO-ABC

NCT02664103

CAPLACIZUMAB

CABLIVI®

Acquired Thrombotic Thrombocytopenic Purpura

LTS16371

Post-HERCULES

NCT02878603

CELIVARONE

Not marketed

Arrhythmia Prophylaxis

DRI10936

ALPHEE

NCT00993382

CELIVARONE

Not marketed

Atrial Fibrillation

DRI5165

MAIA

NCT00233441

CELIVARONE

Not marketed

Arrhythmia

DRI5349

ICARIOS

NCT00232297

CELIVARONE

Not marketed

Atrial Fibrillation

DRI5760

CORYFEE

NCT00232310

CETYLPYRIDINIUM CHLORIDE

Cepacol Canela Power

Hygiene

CPYRY_L_03930

NA

NCT00687037

CETYLPYRIDINIUM CHLORIDE

Cepacol Canela Power

Hygiene

CPYRY_L_04020

NA

NCT00729599

CICLESONIDE

Alvesco

Asthma

DFI6153 (AVE2635A/2001)

NA

NCT00174746

CICLESONIDE

Alvesco

Asthma

EFC6161 (XRP1526B/3028)

NA

NA

CICLESONIDE

Alvesco

Asthma

EFC6163 (XRP1526B/3030)

NA

NCT00174733

CICLESONIDE

Alvesco

Asthma

EFC6164 (XRP1526B/3031)

NA

NCT00174720

CICLESONIDE

Alvesco

Asthma

SFY6160 (XRP1526B/3027)

NA

NCT00254956

CLINDAMYCIN + BENZOYL PEROXIDE

Benzaclin Topical/Duac Topical

Acne Vulgaris

DL6021-0505

NA

NCT00377000

CLOFARABINE

Clolar

Leukemia

BIOV-111

NA

EudraCT: 2004-001853-27

CLOFARABINE

Clolar

Leukemia

BIOV-121

NA

NCT00924443

CLOFARABINE

Clolar

Leukemia

CLO212*

NA

NCT00042341

CLOFARABINE

Clolar

Leukemia

CLO222*

NA

NCT00042354

CLOFARABINE

Clolar

Leukemia

CLO05908

NA

EudraCT: 2015-001172-21

CLOFARABINE

Clolar

Leukemia

CLO08808

NA

EudraCT: 2015-001173-41

CLOFARABINE

Clolar

Leukemia

CLO21800205

NA

NCT00315705

CLOFARABINE

Clolar

Leukemia

CLO24300606

CLASSIC II

NCT00373529

CLOFARABINE

Clolar

Leukemia

CLO34100405

CLASSIC I

NCT00317642

CLOPIDOGREL

Plavix

Angina, Stable Myocardial Infarction

C_9108

ALBION

NCT00360386

CLOPIDOGREL

Plavix

Peripheral Vascular Diseases

C_9253

CASPAR 2004

NCT00174759

CLOPIDOGREL

Plavix

Angina, Stable Myocardial Infarction

EFC10675

CLEAN

NCT00821834

CLOPIDOGREL

Plavix

Angina, Stable Myocardial Infarction

EFC4505

CHARISMA

NCT00050817

CLOPIDOGREL

Plavix

Cardiovascular Diseases

EFC4912A

ACTIVE A

NCT00249873

CLOPIDOGREL

Plavix

Cardiovascular DIseases

EFC4912I

ACTIVE I

NCT00249795

CLOPIDOGREL

Plavix

Angina, Stable Myocardial Infarction

EFC5133

NA

NCT00714961

CLOPIDOGREL

Plavix

Cardiovascular Diseases

EFC5314

CLARINET

NCT00396877

CLOPIDOGREL

Plavix

Acute Coronary Disease

EFC5965

CURRENT/OASIS7

NCT00335452

CLOPIDOGREL

Plavix

Coronary Syndrome, Acute

EFC6720 (DV7314-26)

NA

NCT00325390

CLOPIDOGREL

Plavix

Cardiovascular Diseases

L_8564

NA

NCT00648453

CLOPIDOGREL

Plavix

Thrombosis

L_9317

CASTLE

NCT00716924

CLOPIDOGREL

Plavix

Metabolic Syndrome

L_9842

PROCLAIM

NCT00296803

CLOPIDOGREL

Plavix

Heart Defect, Congenital

LTS10916

CLARINET LT

NCT00833703

CLOPIDOGREL

Plavix

Angina, Stable Myocardial Infarction

PDY4422

PICOLO

NCT00115375

CLOPIDOGREL

Plavix

Peripheral Arterial Disease

SFY10810

NA

NCT00862420

CLOPIDOGREL

Plavix

Cerebral infarction

SFY6913

NA

NCT00386191

CLOPIDOGREL

Plavix

Cerebrovascular accident

CLOPI_L_02452

COMPRESS

NCT00814268

CRF1 ANTAGONIST

Not marketed

Depression

DFI5687

AGATE

EudraCT: 2009-010339-42

References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted